KARL STORZ Investigator Initiated Studies
Provides support in the form of monetary funding and/or equipment loans for relevant clinical and pre-clinical studies conducted by qualified investigators. [Rolling deadline.]
Collaborating for the Advancement of Interdisciplinary Research in Benign Urology
Provides support in the form of monetary funding and/or equipment loans for relevant clinical and pre-clinical studies conducted by qualified investigators. [Rolling deadline.]
A mentored career development program to provide protected time for clinician scientists to focus on training in and conducting clinical pain research. Up to $100K/y salary plus fringe benefits, and $50K/y in research support costs, for up to 3y. [LOI deadline: 11/9/26.]
$65K / y for 3y to support 2nd or 3rd year PhD students and their faculty thesis advisors in advancing cutting-edge research and fostering strong scientific training environments, while supporting the transition to postdoctoral scientist. [Application deadline: 10/27/26.]
Up to $100K / y for 2y to support early career faculty conducting clinical and basic science projects that examines any aspect of the entire spectrum of kidney biology and disease. [Application deadline: 11/19/26.]
5y support for postdoctoral fellows whose projects depart from the mainstream of research in their discipline. [Application deadline: 1/15/27.]
Up to three years support for early-stage postdoctoral scholars to fund rigorous, mentored scientific research and career development. [Expires 7/13/29.]
For groups of NIH-supported investigators to purchase or upgrade a single state-of-the-art commercially available instrument or an integrated instrumentation system. [Expires 7/2/28.]
Supports the purchase of a single commercially available biomedical research instrument currently unavailable in the institution. Instruments must be shared among the users to create new research opportunities, enable reproducible data generation, encourage collaborative research and training, and strengthen long-term research capabilities. [Due dates: 9/25/26, 7/1/27, 7/1/28.]
Supports investigator-initiated, milestone driven clinical trials that need enhanced oversight, and as applicable, include mechanistic studies. [Expires: 7/6/29.]
Supports high-risk, high-reward research that substantially differs from those already being pursued in the investigator's research program or elsewhere. [Deadline: 9/9/26.]